1987
DOI: 10.1002/bjs.1800740305
|View full text |Cite
|
Sign up to set email alerts
|

Survival after resection for carcinoma of the oesophagus

Abstract: During the period 1978-1984, 525 patients referred with cancer of the oesophagus or gastro-oesophageal junction were assessed for operation and cure. After investigation, 276 patients were selected and operated upon, as a rule, 4 weeks after radiotherapy (40 Gy/4 weeks). In 224 patients (81 per cent) the oesophagus and cardia were resected and reconstructed with stomach (69 per cent), colon (21 per cent), free ileal graft (7 per cent) or Roux-en-Y-oesophagojejunostomy (3 per cent). The postresectional hospital… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

1990
1990
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 40 publications
(6 citation statements)
references
References 10 publications
0
6
0
Order By: Relevance
“…After esophageal resection, the stomach is the preferred organ for reconstruction of the digestive tract [1, 2, 3]. For this purpose, either the whole stomach can be interposed or it can be transformed into a narrow gastric tube.…”
Section: Introductionmentioning
confidence: 99%
“…After esophageal resection, the stomach is the preferred organ for reconstruction of the digestive tract [1, 2, 3]. For this purpose, either the whole stomach can be interposed or it can be transformed into a narrow gastric tube.…”
Section: Introductionmentioning
confidence: 99%
“…After surgical resection, the 5-year survival rate is only 12% in stage III disease and all patients with stage IV disease die within 1 year (Moreaux and Horiot, 1980;de Calan et al, 1988;Masurin et al, 1992;Rahamim and Cham, 1993). Because the prognosis decreases rapidly with more advanced stages and palliative oesophagectomy is not associated with increased survival, resection should not be offered to patients with stage IIIB/IV disease (Eeftinck Schattenkerk et al, 1987;Masurin et al, 1992).…”
mentioning
confidence: 99%
“…In the case of lymph node metastases, the 5-year survival was reduced to 13% (2). Figures from our own institution, published by Schattenkerk in 1987, were an estimated 3-year survival of 52% for stages I and I1 (n = 77) and 21% for stage I11 (n = 136) (p < 0.001) (66).…”
Section: Survivalmentioning
confidence: 86%